NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Basilard BioTech

Basilard BioTech

Private
Temecula, CaliforniaHealthcare & Life Scienceshttps://basilardbiotech.com/

Last Round

Pre Seed

Mar 19, 2020

Total Funding Raised

$500,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Basilard BioTech is a biotechnology company that has developed a nanomechanical gene delivery platform designed to transform the growing cell-based therapies market.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

cell deliverymechanoporationgene deliverytransfectioncell engineeringmicrofluidicsbiotech equipmentcell therapycontract development and manufacturing organizationCDMOlab automationnanotechnologylife science toolsnon-viral delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Basilard BioTech Comparables

Compare Basilard BioTech with similar companies based on industry and business-model similarity.

Basilard BioTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Indee Labs
86%
Portal Biotechnologies
82%
Avectas
82%

Basilard BioTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 19, 2020

Key People

Founding team and executive leadership

Brynley Lee

Chief Executive Officer

Executive Team

Basilard BioTech Investors

Notable investors and investment history

Basilard BioTech investors
InvestorRounds
Vertical Venture PartnersPre Seed
University of California, RiversidePre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors grew 194% MoM, reaching 2.4K.

Basilard BioTech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Basilard BioTech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Basilard BioTech's valuation, stock price, and market status.

Firmographic Details

HeadquartersTemecula, California
Employee Range5
Year Founded2019
Last FundingMar 19, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.